Wound patients are increasingly being denied access to important products & procedures – or are being limited in receiving them – because of restrictions in coverage policies. Many coverage challenges stem from a lack of shared clarity surrounding wound care clinical evidence.

----------
The Wound Care Evidence Summit will tackle evidence challenges, gain payer perspectives and build collaborative solutions. 
----------

When:

• April 1-2, 2020 in Washington D.C. 

Who Should Attend?

• Reimbursement, regulatory, policy, researchers and relevant marketing & sales staff from medical societies / associations / clinics / manufacturers / businesses in wound care
• Medical directors of wound clinics and other facilities where wounds are treated
• Clinicians involved in wound care research

Topics To Be Addressed: 

• Current state of wound care evidence, next steps in wound care research & evidence development
• Wound care research challenges and opportunities - the clinical, business & payer perspectives
• Clinical trial design, endpoints, registries and real-world evidence: what is appropriate evidence for coverage from public and commercial payers
• Payer Panel: How coverage policies are developed & the evolving evidentiary expectations necessary for positive coverage policies
• Via keynotes, panels and interactive Q&A sessions, attendees will hear from a diverse range of governement policy makers and private payers who will share perspectives on wound care evidence, how it gets evaluated and considered for coverage decisions, and how evidence needs may shift in the future.
• Solution-oriented breakout sessions will enable attendees to identify next steps and collaboration opportunities to address evidence and coverage issues moving forward.

Registration to open Dec. 1st, 2019.